FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...
The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...
With Cold Weather quickly approaching, The Food and Drug Administration finally approved FluMist to be used at Home.